WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq: INCY) joins the European Organization for Rare Diseases (EURODIS), the National Organization for Rare Disorders (NORD) and other rare disease health organizations and advocates in recognizing the ninth annual Rare Disease Day 2016.
“Rare Disease Day offers a time for patients, physicians, caregivers and advocates to join together to honor those with rare diseases across the globe, among them an estimated 200,000 individuals in the U.S. living with a group of rare blood cancers known as myeloproliferative neoplasms (MPNs),” said Steven Stein, Chief Medical Officer, Incyte Corporation.
